| [1] |
Jabbarvand M, Hashemian H, Khodaparast M, et al. Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors[J]. Ophthalmology, 2016, 123(2): 295－301.
|
| [2] |
Gower EW, Keay LJ, Stare DE, et al. Characteristics of Endophthalmitis after Cataract Surgery in the United States Medicare Population[J]. Ophthalmology, 2015, 122(8): 1625－1632.
|
| [3] |
Schmier JK, Hulme－Lowe CK, Covert DW, et al. An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients[J]. Clin Ophthalmol, 2016, 10: 2121－2127.
|
| [4] |
Tranos P, Dervenis N, Vakalis AN, et al. Current Perspectives of Prophylaxis and Management of Acute Infective Endophthalmitis[J]. Adv Ther, 2016, 33(5): 727－746.
|
| [5] |
Yao K, Zhu Y, Zhu Z, et al. The incidence of postoperative endophthalmitis after cataract surgery in China[J]. Br J Ophthalmol, 2013, 97(10): 1312－1317.
|
| [6] |
Durand ML. Bacterial and Fungal Endophthalmitis[J]. Clin Microbiol Rev, 2017，30(3): 597－613.
|
| [7] |
Fintelmann RE, Naseri A. Prophylaxis of postoperative endophthalmitis following cataract surgery: current status and future directions[J]. Drugs, 2010, 70(11): 1395－1409.
|
| [8] |
Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis[J]. Surv Ophthalmol, 2014, 59(6): 627－635.
|
| [9] |
Wada H, Nojima Y, Ogawa S, et al. Relationship between Virucidal Efficacy and Free Iodine Concentration of Povidone－Iodine in Buffer Solution[J]. Biocontrol Sci, 2016, 21(1): 21－27.
|
| [10] |
Koerner JC, George MJ, Meyer DR, et al. Povidone－iodine concentration and dosing in cataract surgery[J]. Surv Ophthalmol, 2018, 63(6): 862－868.
|
| [11] |
Shimada H, Arai S, Nakashizuka H, et al. Reduced anterior chamber contamination by frequent surface irrigation with diluted iodine solutions during cataract surgery[J]. Acta Ophthalmol, 2017, 95(5): e373－e378.
|
| [12] |
Xiao YC, Hong－Yuan C, Yi－Nan L, et al. Inhibitory Effect of Short－Term Palpebral Margin Cleaning with Antibiotic Eye Drops on Ocular Surface Flora before Cataract Extraction: A New Preoperative Antibacterial Method[J]. Chin Med Sci J, 2022, 37(2): 118－126.
|
| [13] |
Thanathanee O, Pulnitiporn R, Anutarapongpan O, et al. Effect of Eyelid Margin Cleaning on Conjunctival and Eyelid Bacterial Flora Before Intraocular Surgery[J]. Semin Ophthalmol, 2018, 33(6): 808－812.
|
| [14] |
Murphy CC, Nicholson S, Quah SA, et al. Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery[J]. Br J Ophthalmol, 2007, 91(10): 1350－1353.
|
| [15] |
Rush SW, Vu D, Rush RB. The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery[J]. J Ophthalmol, 2015: 813697.
|
| [16] |
Schelonka LP, SaBell MA. Postcataract endophthalmitis prophylaxis using irrigation, incision hydration, and eye pressurization with vancomycin[J]. Clin Ophthalmol, 2015, 9: 1337－1345.
|
| [17] |
Witkin AJ, Chang DF, Jumper JM, et al. Vancomycin－Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes[J]. Ophthalmology, 2017, 124(5): 583－595.
|
| [18] |
Todorich B, Faia LJ, Thanos A, et al. Vancomycin－Associated Hemorrhagic Occlusive Retinal Vasculitis[J]. Am J Ophthalmol, 2018, 188: 131－140.
|
| [19] |
Haripriya A, Chang DF, Ravindran RD. Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries[J]. Ophthalmology, 2017, 124(6): 768－775.
|
| [20] |
Vieira IV, Boianovsky C, Saraiva TJ, et al. Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification[J]. Arq Bras Oftalmol, 2017, 80(3): 165－167.
|
| [21] |
Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries[J]. J Cataract Refract Surg, 2019, 45(9): 1226－1233.
|
| [22] |
Melega MV, Alves M, Cavalcanti LR, et al. Safety and efficacy of intracameral moxifloxacin for prevention of post－cataract endophthalmitis: Randomized controlled clinical trial[J]. J Cataract Refract Surg, 2019, 45(3): 343－350.
|
| [23] |
Dave VP, Singh VM, Reddy JC, et al. Clinical features and microbiology of post－cataract surgery endophthalmitis with and without intracameral moxifloxacin prophylaxis: Endophthalmitis prophylaxis study report 3[J]. Indian J Ophthalmol, 2022, 70(1): 158－163.
|
| [24] |
Shenoy P, Goh E, Kashikar R, et al. Impact of prophylactic intracameral moxifloxacin on post－cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India[J]. Int Ophthalmol, 2021, 41(8): 2729－2736.
|
| [25] |
Shorstein NH, Liu L, Carolan JA, et al. Endophthalmitis Prophylaxis Failures in Patients Injected With Intracameral Antibiotic During Cataract Surgery[J]. Am J Ophthalmol, 2021, 227: 166－172.
|
| [26] |
Arshinoff SA, Felfeli T, Modabber M. Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies[J]. J Cataract Refract Surg, 2019, 45(11): 1568－1574.
|
| [27] |
Penaranda－Henao MM, Reyes－Guanes JM, Munoz－Ortiz JM, et al. Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report[J]. Ocul Immunol Inflamm, 2021, 29(7－8): 1366－1369.
|
| [28] |
de Sousa CL, Meireles AC, Schapira E, et al. The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high－volume cataract surgery center[J]. Sci Rep, 2023, 13(1): 18031.
|
| [29] |
Daien V, Le Pape A, Heve D, et al. Incidence, Risk Factors, and Impact of Age on Retinal Detachment after Cataract Surgery in France: A National Population Study[J]. Ophthalmology, 2015, 122(11): 2179－2185.
|
| [30] |
Wang M, Liu Y, Dong H. Effect of cefuroxime intracameral injection antibiotic prophylactic on postoperative endophthalmitis wound post－cataract[J]. Int Wound J, 2023, 20(5): 1376－1383.
|
| [31] |
Promelle V, Jany B, Drimbea A, et al. Tolerability of intracameral cefuroxime during cataract surgery in case of penicillin allergy[J]. J Fr Ophtalmol, 2015, 38(4): 283－287.
|
| [32] |
Moisseiev E, Levinger E. Anaphylactic reaction following intracameral cefuroxime injection during cataract surgery[J]. J Cataract Refract Surg, 2013, 39(9): 1432－1434.
|
| [33] |
Kato A, Horita N, Namkoong H, et al. Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta－analysis of 6.8 million eyes[J]. Sci Rep, 2022, 12(1): 17416.
|
| [34] |
Bowen RC, Zhou AX, Bondalapati S, et al. Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta－analysis[J]. Br J Ophthalmol, 2018, 102(9): 1268－1276.
|
| [35] |
Ma X, Xie L, Huang Y. Intraoperative Cefuroxime Irrigation Prophylaxis for Acute－Onset Endophthalmitis After Phacoe mulsification Surgery[J]. Infect Drug Resist, 2020, 13: 1455－1463.
|
| [36] |
Ma W, Hou G, Wang J, et al. Evaluation of the effect of gentamicin in surgical perfusion solution on cataract postoperative endophthalmitis[J]. BMC Ophthalmol, 2022, 22(1): 410.
|
| [37] |
Reddy JK, Sundaram V, Dani S, et al. Comparison of different endophthalmitis prophylactic measures in cataract surgery[J]. Indian J Ophthalmol, 2022, 70(11): 4000－4002.
|
| [38] |
Topete A, Tang J, Ding X, et al. Dual drug delivery from hydrophobic and hydrophilic intraocular lenses: in－vitro and in－vivo studies[J]. J Control Release, 2020, 326: 245－255.
|
| [39] |
Ongkasin K, Masmoudi Y, Tassaing T, et al. Supercritical loading of gatifloxacin into hydrophobic foldable intraocular lenses－Process control and optimization by following in situ CO(2) sorption and polymer swelling[J]. Int J Pharm, 2020, 581：119247.
|
| [40] |
Lamprogiannis L, Karamitsos A, Karagkiozaki V, et al. Design and fabrication of drug－eluting polymeric thin films for applications in ophthalmology[J]. IET Nanobiotechnol, 2018, 12(8): 1074－1079.
|
| [41] |
Li M, Xu JW, Li J, et al. A novel gatifloxacin－loaded intraocular lens for prophylaxis of postoperative endophthalmitis[J]. Bioact Mater, 2023, 20: 271－285.
|
| [42] |
中华医学会眼科学分会青光眼学组，中华医学会眼科学分会眼底病学组，中华医学会眼科学分会白内障及屈光手术学组，等. 中国眼科手术后感染性眼内炎诊疗专家共识(2022年)[J]. 中华眼科杂志，2022, 58(7): 487－499.
|
| [43] |
Soekamto C, Rosignoli L, Zhu C, et al. Visual outcomes of acute bacterial endophthalmitis treated with adjuvant intravitreal dexamethasone[J]. Indian J Ophthalmol, 2022, 70(8): 2835－2841.
|
| [44] |
Ye Y, He J, Qiao Y, et al. Mild temperature photothermal assisted anti－bacterial and anti－inflammatory nanosystem for synergistic treatment of post－cataract surgery endophthalmitis[J]. Theranostics, 2020, 10(19): 8541－8557.
|
| [45] |
Qiao Y, Li Y, Ye Y, et al. Gallium－Based Nanoplatform for Combating Multidrug－Resistant Pseudomonas aeruginosa and Postoperative Inflammation in Endophthalmitis Secondary to Cataract Surgery[J]. ACS Appl Mater Interfaces, 2022, 14(46): 51763－51775.
|
| [46] |
Chiquet C, Lina G, Benito Y, et al. Polymerase chain reaction identification in aqueous humor of patients with postoperative endophthalmitis[J]. J Cataract Refract Surg, 2007, 33(4): 635－641.
|
| [47] |
Chiquet C, Cornut PL, Benito Y, et al. Eubacterial PCR for bacterial detection and identification in 100 acute postcataract surgery endophthalmitis[J]. Invest Ophthalmol Vis Sci, 2008, 49(5): 1971－1978.
|
| [48] |
Kosacki J, Boisset S, Maurin M, et al. Specific PCR and Quantitative Real－Time PCR in Ocular Samples from Acute and Delayed－Onset Postoperative Endophthalmitis[J]. Am J Ophthalmol, 2020, 212: 34－42.
|
| [49] |
Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group[J]. Arch Ophthalmol, 1995, 113(12): 1479－1496.
|
| [50] |
Crosby NJ, Westcott M, Michael E, et al. Comparative Outcomes of Primary Vitrectomy Versus Tap and Inject for Endophthalmitis Following Phacoemulsification Cataract Surgery[J]. Ocul Immunol Inflamm, 2022, 30(3): 727－733.
|
| [51] |
Januschowski K, Boden KT, Szurman P, et al. Effectiveness of immediate vitrectomy and intravitreal antibiotics for post－injection endophthalmitis[J]. Graefes Arch Clin Exp Ophthalmol, 2021, 259(6): 1609－1615.
|
| [52] |
Ho IV, Fernandez－Sanz G, Levasseur S, et al. Early Pars Plana Vitrectomy for Treatment of Acute Infective Endophthalmitis[J]. Asia Pac J Ophthalmol (Phila), 2019, 8(1): 3－7.
|
| [53] |
Iu L, Chan HY, Li G, et al. Acute postoperative endophthalmitis after cataract operation: result of early vitrectomy within 24 hours of presentation[J]. Eye (Lond), 2023, 37(11): 2344－2350.
|
| [54] |
Far PM, Yeung SC, Farimani PL, et al. Tap and inject versus pars plana vitrectomy for postprocedural endophthalmitis: A Meta－analysis[J]. Retina, 2021, 41(10): 2009－2016.
|